The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.

MLA

Fast, Søren, et al. “The Majority of Danish Nontoxic Goitre Patients Are Ineligible for Levothyroxine Suppressive Therapy.” Clinical Endocrinology, vol. 69, no. 4, Oct. 2008, pp. 653–58. EBSCOhost, https://doi.org/10.1111/j.1365-2265.2008.03241.x.

APA

Fast, S., Bonnema, S. J., & Hegedüs, L. (2008). The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy. Clinical Endocrinology, 69(4), 653–658. https://doi.org/10.1111/j.1365-2265.2008.03241.x

Chicago

Fast, Søren, Steen Joop Bonnema, and Laszlo Hegedüs. 2008. “The Majority of Danish Nontoxic Goitre Patients Are Ineligible for Levothyroxine Suppressive Therapy.” Clinical Endocrinology 69 (4): 653–58. doi:10.1111/j.1365-2265.2008.03241.x.